PKG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
PKG looks like a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The setup is constructive: analysts have turned more bullish with multiple Buy upgrades and higher price targets, technicals are improving, options sentiment is supportive, and congress trading is net positive. Given the user wants a direct call and is not waiting for a perfect entry, I would buy here rather than hold out for a better price.
Pre-market price is 218.14, sitting above the pivot at 213.13 and near first resistance at 220.46. MACD histogram is positive and expanding, which supports short-term upside momentum. RSI_6 at 57.52 is neutral-to-bullish, meaning the stock is not overbought. Moving averages are converging, which often precedes a trend continuation or breakout. Overall, the trend is mildly bullish with room to test 220.46 and then 224.98.
Analyst upgrades are the biggest catalyst: UBS upgraded PKG to Buy with a $248 target and Deutsche Bank upgraded to Buy with a $256 target. UBS cited improving demand, tight supply, pricing power, and potential annualized EBITDA uplift from the June price hike. The company also benefits from high utilization, prior capacity cuts, and no exposure to the fragmented European market. Congress trading is also favorable, with 2 purchases versus 1 sale in the last 90 days, indicating positive institutional-like political sentiment.
There has been no recent news in the last week, so there is no fresh event-driven catalyst beyond analyst commentary. Hedge fund and insider activity are neutral, so there is no strong conviction from those groups. Technical trend indicators are improving but not yet strong, and the stock is close to resistance near 220.46, which may slow near-term upside.
Latest quarter season: Q1 2026. Financial commentary from analysts says PKG reported operating EPS above Street expectations, with evidence of better-than-expected demand continuing into early Q2. However, Q2 EPS guidance was below estimates because of maintenance costs and other non-operational headwinds rather than weakening core demand. Overall, the latest quarter points to solid operational performance and healthy underlying demand growth.
Analyst sentiment has improved meaningfully over the past month. Deutsche Bank upgraded PKG from Hold to Buy with a $256 target, and UBS upgraded it from Neutral to Buy with a $248 target after previously raising its target. Truist remains Buy/Overweight positive, while earlier UBS and other firms had more neutral stances. The Wall Street pros view is constructive overall: strong pricing power, good margins, and attractive operational execution are the bullish arguments, while near-term cost pressures and slightly soft guidance are the main drawbacks. Net net, analysts are increasingly bullish.
